Orthofix Medical Inc. (NASDAQ:OFIX) Shares Acquired by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. increased its stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 139.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,623 shares of the medical device company's stock after acquiring an additional 22,471 shares during the quarter. Balyasny Asset Management L.P. owned about 0.10% of Orthofix Medical worth $674,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Renaissance Technologies LLC boosted its holdings in shares of Orthofix Medical by 166.9% in the fourth quarter. Renaissance Technologies LLC now owns 82,190 shares of the medical device company's stock valued at $1,435,000 after acquiring an additional 51,399 shares in the last quarter. Barclays PLC boosted its holdings in shares of Orthofix Medical by 38.8% in the third quarter. Barclays PLC now owns 122,472 shares of the medical device company's stock valued at $1,912,000 after acquiring an additional 34,210 shares in the last quarter. Kirr Marbach & Co. LLC IN purchased a new stake in shares of Orthofix Medical in the fourth quarter valued at about $532,000. JPMorgan Chase & Co. boosted its holdings in shares of Orthofix Medical by 480.7% in the third quarter. JPMorgan Chase & Co. now owns 84,379 shares of the medical device company's stock valued at $1,318,000 after acquiring an additional 69,848 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Orthofix Medical during the fourth quarter worth about $1,003,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Orthofix Medical Stock Down 1.4%

NASDAQ OFIX traded down $0.17 during trading hours on Wednesday, reaching $11.82. 83,517 shares of the company traded hands, compared to its average volume of 262,250. Orthofix Medical Inc. has a 12 month low of $10.50 and a 12 month high of $20.73. The company has a current ratio of 2.39, a quick ratio of 1.11 and a debt-to-equity ratio of 0.25. The stock has a market capitalization of $461.40 million, a PE ratio of -3.78 and a beta of 0.87. The company has a 50 day moving average of $14.21 and a two-hundred day moving average of $16.72.

Insider Buying and Selling at Orthofix Medical

In other news, insider Lucas Vitale sold 4,287 shares of the firm's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $16.60, for a total value of $71,164.20. Following the transaction, the insider now directly owns 135,317 shares in the company, valued at approximately $2,246,262.20. This trade represents a 3.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Engine Capital Management, Lp purchased 100,000 shares of Orthofix Medical stock in a transaction dated Wednesday, May 7th. The stock was acquired at an average price of $12.31 per share, for a total transaction of $1,231,000.00. Following the completion of the transaction, the insider now owns 3,544,807 shares in the company, valued at approximately $43,636,574.17. The trade was a 2.90% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 8,475 shares of company stock worth $128,065 in the last ninety days. 1.30% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts recently commented on OFIX shares. Roth Mkm reissued a "buy" rating and set a $22.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Canaccord Genuity Group reissued a "buy" rating and set a $24.00 price objective on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, StockNews.com downgraded shares of Orthofix Medical from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.